Synthatex Fine Chemicals Ltd. was established in January 2002 to address issues in sourcing technology, and contract research in the field of organic synthesis, in addition to performing research of new molecules for drug discovery.
Synthatex provides contract chemical research and custom synthesis capabilities that are designed to meet the outsourcing needs of the biopharmaceutical and biotechnology industries. Our modern facilities provide an impeccable quality of chemical products to meet the precise needs of our customers.
In a joint venture with Morphochem AG (Germany) Synthatex has started three year research project in the field of drug discovery based on Multi-Component Reaction technology (MCR). Throughout this collaboration, the two companies will be developing and characterizing about a ten thousand member library of highly diverse small molecules for drug discovery purposes. For this project, Synthatex is being supported by the Chief Scientist of Israeli Ministry of Industry, Trade and Labor.
Our staff of experienced chemists has extensive experience in multi-step organic synthesis and medicinal chemistry. We guarantee that our products meet or exceed the purity specifications of our customers. Synthatex has already established collaborations in the field of organic synthesis with the most leading local pharmaceutical companies as well as with European and American pharmaceutical companies.
|